CENCORA
LIVE

Serial Number

97765135

Owner

AmerisourceBergen Corporation

Attorney

Anita B. Polott

Filing Date

Jan 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CENCORA Trademark

Serial Number: 97765135

CENCORA is a trademark filed by AmerisourceBergen Corporation on January 23, 2023. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

AmerisourceBergen Corporation (57 trademarks)

1 West First Avenue
Conshohocken, PA 19428

Entity Type: 03

CENCORA, INC.

1 WEST FIRST AVENUE
CONSHOHOCKEN, PA 19428

Entity Type: 03

Trademark Details

Filing Date

January 23, 2023

Registration Date

Not Registered

Published for Opposition

December 17, 2024

Goods & Services

Medical analysis services, namely, medical diagnostic testing, monitoring and reporting in the field of human disease treatment; providing medical information, namely, providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices being the specific diagnosis, line of therapy, stage of disease and regimen information; providing clinical and home health care services, namely, providing medical and healthcare information relating to therapeutic properties of pharmaceuticals; providing medical and healthcare counseling to patients in the field of administration of medications; providing medical and health clinical services and home health care services; providing medical care information; Health care services, namely, providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; providing medical, health and veterinary information services for the pharmaceutical and medical sectors; providing information services relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals for the pharmaceutical and medical sectors; providing medical and health counseling and pharmaceutical advice services related to workplace and personnel health; healthcare services; services of providing medical and healthcare information on medical substances; medical and healthcare consulting, namely, analyzing and reporting of discussions about human disease treatment; medical services in the nature of administration and management of sophisticated pharmaceutical therapies; providing a website featuring customisable medical, health, veterinary, pharmaceutical and medical biotechnical information and analysis about legislative regulatory developments in the field of healthcare; remote healthcare and telemedicine services, namely, healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; remote healthcare and telemedicine services, namely, providing patients with health information relating to their medical condition; beauty and health care consulting services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies; providing information on health and nutrition in the field of animal management; providing a website featuring information to retail customers of pharmacies over a global computer network with regard to health, wellness and pharmacy news; providing information, news and commentary in the field of current events relating to the healthcare industry and healthcare legislation and regulation; providing on-line information, news and commentary in the field of health and wellness relating to healthy diets and activities for male and female infants, children, teenagers, adults and seniors and to illnesses and treatments affecting them; pharmaceutical consultation; providing medical information

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 10, 2026 EXRA
SOU EXTENSION 2 GRANTED
Feb 9, 2026 EX2G
SOU EXTENSION 2 FILED
Feb 9, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 9, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 12, 2025 EXRA
SOU EXTENSION 1 GRANTED
Aug 11, 2025 EX1G
SOU EXTENSION 1 FILED
Aug 11, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 11, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2024 TROA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Apr 18, 2024 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 18, 2024 PARI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 16, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 16, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 23, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 19, 2023 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 18, 2023 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 13, 2023 NWOS
NEW APPLICATION ENTERED
Jan 26, 2023 NWAP